Association between vitamin D receptor poly(A) polymorphism and breast cancer risk: A meta-analysis

Tumor Biology

Volumn 35, Issue 1, 2014, Pages 589-593

  Xu, Jinjiang ^a   Li, Hongyu ^a   Gu, Lixue ^a   Zhou, Xiaoping ^a  

^a JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Meta analysis; VDR

Indexed keywords

POLYADENYLIC ACID; VITAMIN D RECEPTOR;

ARTICLE; BREAST CANCER; CANCER RISK; EMBASE; ETHNICITY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; MEDLINE; PRIORITY JOURNAL; PUBLISHING; RECEPTOR GENE; RISK ASSESSMENT; VITAMIN D RECEPTOR GENE;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ODDS RATIO; POLY A; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RECEPTORS, CALCITRIOL; RISK;

EID: 84894473665     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1082-7     Document Type: Article

References (26)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10-29.
3. Bertos NR, Park M. Breast cancer-one term, many entities? J Clin Invest. 2011;121:3789-96.
4. Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJ, et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet. 2011;378:1461-84.
5. Higgins MJ, Baselga J. Breast cancer in 2010: novel targets and therapies for a personalized approach. Nat Rev Clin Oncol. 2011;8:65-6.
6. Bertone-Johnson ER. Vitamin D and breast cancer. Ann Epidemiol. 2009;19:462-7.
7. Kostner K, Denzer N, Muller CS, Klein R, Tilgen W, Reichrath J. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res. 2009;29:3511-36.
8. McCullough ML, Stevens VL, Diver WR, Feigelson HS, Rodriguez C, Bostick RM, et al. Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study. Breast Cancer Res. 2007;9:R9.
9. Trabert B,Malone KE, Daling JR, Doody DR, Bernstein L, Ursin G, et al. Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African- American women. Breast Cancer Res. 2007;9:R84.
10. Rollison DE, Cole AL, Tung KH, Slattery ML, Baumgartner KB, Byers T, et al. Vitamin D intake, vitamin D receptor polymorphisms, and breast cancer risk among women living in the southwestern U.S. Breast Cancer Res Treat. 2012;132:683-91.
11. Chakraborty A, Mishra AK, Soni A, Regina T, Mohil R, Bhatnagar D, et al. Vitamin D receptor gene polymorphism(s) and breast cancer risk in north Indians. Cancer Detect Prev. 2009;32:386-94.
12. Wedren S, Magnusson C, Humphreys K, Melhus H, Kindmark A, Stiger F, et al. Associations between androgen and vitamin D receptor microsatellites and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:1775-83.
13. Dunning AM,McBride S, Gregory J, Durocher F, Foster NA, Healey CS, et al. No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer. Carcinogenesis. 1999;20:2131-5.
14. Guy M, Lowe LC, Bretherton-Watt D, Mansi JL, Peckitt C, Bliss J, et al. Vitamin D receptor gene polymorphisms and breast cancer risk. Clin Cancer Res. 2004;10:5472-81.
15. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-60.
16. DerSimonian R, LairdN.Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88.
17. Mantel N, HaenszelW. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-48.
18. Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-34.
19. Bretherton-Watt D, Given-Wilson R,Mansi JL, Thomas V, Carter N, Colston KW. Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population. Br J Cancer. 2001;85:171-5.
20. Ingles SA, Garcia DG, Wang W, Nieters A, Henderson BE, Kolonel LN, et al. Vitamin D receptor genotype and breast cancer in Latinas (United States). Cancer Causes Control. 2000;11:25-30.
21. Platt J, Baxter N, Zhong T. Breast reconstruction after mastectomy for breast cancer. CMAJ. 2011;183:2109-16.
22. van der Groep P, van der Wall E, van Diest PJ. Pathology of hereditary breast cancer. Cellr Oncol (Dordr). 2011;34:71-88.
23. Yao F, Fang Y, Chen B, Jin F,Wang S. Association between the nbs1 glu185gln polymorphism and breast cancer risk: a meta-analysis. Tumour Biol. 2013;34:1255-62.
24. Levin GP, Robinson-Cohen C, de Boer IH, Houston DK, Lohman K, Liu Y, et al. Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes. JAM.A. 2012;308:1898-905.
25. Orlow I, Roy P, Reiner AS, Yoo S, Patel H, Paine S, et al. Vitamin D receptor polymorphisms in patients with cutaneous melanoma. Int J Cancer. 2012;130:405-18.
26. Tang C, Chen N, Wu M, Yuan H, Du Y. Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis. Breast Cancer Res Treat. 2009;117:391-9.